EU approves Biogen's Spinraza for lead genetic cause of infant death

(Reuters) - Biogen Inc on Thursday said its drug, Spinraza, had secured European Union approval to treat spinal muscular atrophy (SMA), a leading genetic cause of death in infants.

Indonesia tobacco bill would open tap for ads aimed at kids, health official says

JAKARTA (Reuters) - A proposed Indonesian tobacco law will roll back regulations to discourage smoking in a country that already has one of the highest smoking rates in the world and open the floodgates to advertising aimed at teenagers, a health ministry official said.

Philips in deals with U.S. hospitals on use of its gene data platform for cancer research

AMSTERDAM (Reuters) - Dutch healthcare technology company Philips said Thursday it had reached deals with New York's Memorial Sloan Kettering Cancer Center (MSK) and Utah-based Intermountain Healthcare for them to use its genomics platform for cancer research and treatment.